Day 29 of My Journey from 64 to 65 ProArgi9+ L-Arginine a Primer for Its Power?
I wanted to share some further scientific facts about l-arginine with you, however I must keep reminding everyone that l-arginine is NOT the only ingredient in ProArgi9+. Without those extra ingredients ProArgi9+ would be as in effective as all the other l-arginine supplements that are sold today. If you really want to know why this is just drop me a message, my details are all over this web site. And when the article below was written ProArgi9+ was still over a decade away from being developed.
L-Arginine: A Primer for Its Power part 1: by Dr. J. Joseph Prendergast.
In the beginning, Dr. Robert Furchgott in 1980 found that the endothelial lining of the walls of blood vessels made a substance that kept the vessels smooth and dilated. This was Nitric Oxide (NO). Soon it was discovered that l-arginine converts to NO in the endothelium. I learned about l-arginine in 1991 when I was in a professional association teaching physicians with Victor J. Dzau, MD when he was director of Cardiovascular Research at Stanford University Medical Center. Dr. Dzau was appointed Chancellor for Health Affairs at Duke University and President and CEO of the Duke University Health System effective July 1, 2004. He is also James B. Duke Professor of Medicine and Director of Molecular and Genomic Vascular Biology at Duke. Prior to that, he was the Hersey Professor of the Theory and Practice of Physic (Medicine) at Harvard Medical School, Chairman of the Department of Medicine at Brigham, and Women’s Hospital, and Physician-in-Chief and Director of Research at Brigham and Women’s Hospital, Boston. Prior to his work at Harvard and Brigham and Women’s, he served as Arthur Bloomfield Professor and Chairman of the Department of Medicine at Stanford. He was the first to explain to me the extraordinary observation that atherosclerotic heart disease could not only be controlled but reversed. His research touched on clinical improvement and was forwarded with multiple studies by John P. Cooke, MD. Dr. Cooke is presently head of Cardiovascular Research at Stanford. Very productive on new insights and understanding of vascular health, you will find his name on many of the research papers in the following documents. White papers, as I have labelled this, have characteristically been a document, a summary fixed in time that delivers knowledge and philosophy about some situation. This, on the other hand, is to be a living document updated continuously. It is my task to continue this project forever since it is so personal to me. I will need your help too to pass on significant information. My personal story began with meeting these individuals. Since I had been noted to be heavily laden with atherosclerosis in my abdominal arteries at age 37, I took an uncommon interest in their research into the reversal of atherosclerosis. After 10 years of l-arginine use, I had no evidence of atherosclerosis. The testing available today with arterial wave form analysis allows me to monitor how well I’m doing with my personal regression therapy. Part 2 follows tomorrow.
#myjourneyfrom64to65 is starting with #PurifyKit #Smartmeal #SynergyWorlWide #ProArgi9+
The best way to reach me is on Twitter @CampbellB_Young
Join our Facebook Page Elite Health Group
Your experience may not be the same as what is described in any of our testimonials, reviews, or endorsements. Our information is only a shared experience by an individual and describes only that person’s experience using our products and is not a guarantee, promise, or reflection of the feelings and outcomes of every user. Nothing printed has been approved or endorsed by the FDA.